Case Study: Dasa advances personalized cancer care with SOPHiA GENETICS multimodal solutions

DASA leverages on the SOPHiA GENETICS multimodal approach in the fight against cancer

Dasa, a major Brazilian diagnostics and healthcare network, needed a better way to support personalized medicine in oncology—helping clinicians detect disease-causing variants, choose the right therapy, and monitor treatment effectiveness across a large volume of patient data. To address this, Dasa partnered with SOPHiA GENETICS and began using the SOPHiA DDM™ platform, including solutions for genomics, radiomics, and trial matching.

SOPHiA GENETICS implemented SOPHiA DDM™ for Radiomics and SOPHiA DDM™ Trial Match to help Dasa better analyze and organize oncology data, support more data-driven decisions, and accelerate clinical trial recruitment. The partnership also enabled Dasa to grow its genomic analyses across oncology and improve individualized patient follow-up, while expanding collaboration across its hospital network.

Dasa

Andreza Almeida Senerchia

Head of Clinical Research